Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyWellCare Transplant Prior Auth & Coverage Update |…
    Ask Trek AI about this page
    ModifiedWellCarePolicy CP.MP.247

    Transplant Service Documentation Requirements

    Customize your policy alerts

    Sign up for WellCare Policy CP.MP.247 alerts

    Get alerted when Policy CP.MP.247 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines required clinical documentation for pre-transplant evaluation, transplant listing, and post-transplant follow-up office visit prior authorization requests for solid organ and stem cell/bone marrow transplants for members of WellCare-affiliated health plans.

    Policy Summary
    PayerWellCare
    PolicyTransplant Service Documentation Requirements
    Policy CodePolicy CP.MP.247
    Change TypeAdded and revised documentation and authorization requirements
    Effective Date
    Next Review Date
    Key ActionSubmit a completed prior authorization form and the specified supporting documentation (history & physical, labs, organ-specific testing, psychosocial evaluation, and discharge summary for post-transplant visits) to obtain authorization.
    SourceLink
    POLICY UPDATE CHANGES

    Clarified in description that the policy applies to transplant evaluation and listing requests.

    Added requirements for post-transplant follow up visits and a note regarding other authorization requirements for services unrelated to post-transplant follow-up office visits.

    Adjusted time requirement to reflect 12 months for kidney transplants and 6 months for other transplants in documentation timing for history/physical, basic labs, and psychosocial evaluation.

    6 monthsauthorization period — evaluation
    12 monthsauthorization period — listing

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    90 days
    drug screen window
    1 yearinfectious serologies window
    105,000+OPTN waitlist size
    Centene/WellCaredocument owner

    Coverage Criteria

    Documentation-based medical necessity criteria

    Covered when ALL of the following are met

    Transplant evaluation requests: Include appropriate prior authorization form; routine complete history and physical within one year including history of present illness with current medication list, past medical/family/social history, complete review of systems, and physical exam with height, weight and body mass index (BMI).history/physical within 12 months

    Approved evaluation requests are effective for six months.

    Initial and subsequent transplant listing requests: Include appropriate prior authorization form; letter of medical necessity signed by a transplant service provider; complete history and physical performed by a transplant service provider within 12 months for kidney transplant requests or within six months for other transplant requests; basic labs (complete chemistry/liver function tests and CBC) within 12 months for kidney or six months for other transplants; organ-specific testing, imaging, and documentation as specified; annual dental evaluation and clearance; routine health screening exams per standards of care (not required for autologous stem cell transplant); appropriate comorbidity testing/clearance (including cardiology as indicated); serum or urine drug screen within 90 days of request; infectious disease screening as applicable within one year (see organ-specific list); and a detailed psychosocial evaluation and clearance within 12 months for kidney and six months for other transplants.listing documentation timeframes vary by organ (kidney 12 months; others 6 months)

    Approved listings are effective for 12 months; transplant admissions require separate authorization.

    Post-transplant follow-up office visits: Include appropriate prior authorization form and the discharge summary or history and physical from the inpatient transplant admission.N/A

    For authorization requirements for services unrelated to post-transplant follow-up office visits, check the health plan's prior authorization tool.

    Additional facility authorization: Authorizations for transplant services at multiple facilities or additional evaluations after listing are medically necessary if either the member has an episode of illness resulting in a change to transplant eligibility status or the member is admitted to a geographically closer facility and is not stable for transfer to the previously approved facility due to declining medical status.N/A

    Supports multiple-authority approvals under specific clinical circumstances.

    For corneal transplant, pancreatic islet cell autotransplant after pancreatectomy, and parathyroid autotransplant after thyroidectomy, providers must complete the Health Plan–specific prior authorization form available on the Health Plan website. These specific transplant types are handled via the plan form and are not processed under routine evaluation/listing authorizations described elsewhere in this policy.

    Coverage determinations under this policy are subject to the terms, conditions, exclusions and limitations of the member’s coverage documents (for example, evidence of coverage, certificate of coverage, policy or contract). Where applicable, state Medicaid provisions and federal or regulatory requirements take precedence over this clinical policy. This policy is a guide to medical necessity and does not guarantee payment; providers should verify member-specific benefits and applicable legal/regulatory rules when submitting authorization requests.

    Coding & Timing

    Coding references (informational)mixed
    CPT referencedCPT codes referenced in policy for informational purposes; specific codes not listed in this part of the document.
    Timing windows for required documentation/tests
    History & physical timingComplete H&P: within 12 months for kidney transplants; within 6 months for other transplants.
    Basic labs timingComplete chemistry/LFTs and CBC: within 12 months for kidney transplants; within 6 months for other transplants.
    Drug screen windowSerum or urine drug screen results must be within 90 days of the request.
    Infectious serology timingMany infectious disease serologies (e.g., CMV, VZV, EBV, Hepatitis B, Hepatitis C, RPR, HIV) within one year unless baseline antibody positive; if baseline positive, follow CMS/plan guidance (viral load/CD4 within 3 months if applicable).

    Provider Actions & Authorization Requirements

    Prior Authorization

    Prior authorization required for evaluation, listing, and post‑transplant follow‑up

    Prior authorization is required for transplant evaluation requests, transplant listing requests, and post‑transplant follow‑up office visits; inpatient transplant admissions require a separate prior authorization.

    • Approved transplant evaluation authorizations are effective for six months.
    • Approved transplant listing authorizations are effective for 12 months; after 12 months a new authorization with updated documentation is required.
    • Inpatient transplant admissions are not covered under evaluation/listing authorizations and must be authorized separately.
    Prior Authorization

    Prior authorization must document medical necessity consistent with plan coverage

    Authorization requests must include documentation showing the transplant service meets the Health Plan's medical necessity criteria and is consistent with applicable guidance and NCDs/LCDs; providers should verify Medicare/Medicaid‑specific coverage when applicable.

    Definitions

    Pre-transplant evaluation — clinical workup
    DefinitionPre‑transplant evaluation: the clinical workup required to determine transplant candidacy, including history and physical, laboratory testing, imaging and organ‑specific studies, infectious disease screening, detailed psychosocial assessment, and other organ‑specific testing as indicated.
    Core clinical elementsHistory of present illness, medication list, past medical/family/social history, review of systems, and physical exam including height, weight, and BMI.
    Laboratory & screening elementsBasic labs (chemistry/LFTs, CBC), infectious disease serologies as applicable (CMV, VZV, EBV, Hep B/C, RPR, HIV, TB testing), and drug screen per timing requirements.
    Organ‑specific testingAs applicable: liver (INR, MELD/PELD, hepatitis serologies, imaging, biopsy), kidney (GFR/creatinine clearance), heart (echo, right heart catheterization/PVR, NYHA class, peak VO2), lung (PFTs, chest imaging, 6‑minute walk), pancreas (BMI, insulin history), intestine (TPN failure documentation), stem cell (bone marrow biopsy, ECOG/Karnofsky, donor ID for allogeneic).
    Psychosocial assessmentDetailed psychosocial evaluation and clearance within 12 months for kidney transplants and within 6 months for other transplants.

    Organ- and Candidate-Specific Evaluation Requirements

    Organ- and transplant-type specific evaluation requirements

    Organ-specific and transplant-type specific evaluation items required as part of listing documentation

    Liver: INR, MELD/PELD score, hepatitis serologies, imaging studies (MRI, CT, ultrasound), and liver biopsy as indicated.N/A

    Infectious disease screening requirements (e.g., CMV, EBV, hepatitis, HIV, RPR, PPD/T-Spot/QuantiFERON) apply as listed.

    Kidney: Glomerular filtration rate (GFR) or creatinine clearance if not on dialysis; history/physical and basic labs within 12 months for listing.N/A

    Annual dental evaluation and psychosocial evaluation timing for kidney listing is within 12 months.

    Heart:

    Contraindications

    The policy does not enumerate an explicit list of absolute contraindications in this excerpt. It notes that active infection and significant comorbidity may affect transplant candidacy and that such clinical conditions should be considered during evaluation and listing decisions. Transplant admissions are handled separately and require their own prior authorization when applicable.

    Evaluation Requirements

    Step Therapy

    Evaluation must include H&P, labs, organ‑specific testing, infectious disease screening, psychosocial, and dental clearance

    A complete pre‑transplant evaluation must include a detailed history and physical, basic laboratory testing, organ‑specific testing/imaging as listed, infectious disease screening as applicable, psychosocial evaluation, and dental clearance when required.

    • History & physical with HPI, medication list, past medical/family/social history, ROS, and physical exam including height, weight and BMI.
    • Basic labs (CBC, chemistry/LFTs) within applicable timeframes (kidney 12 months; other organs six months).
    • Infectious disease screening (CMV, VZV, EBV, Hepatitis B/C, HIV, RPR, TB testing) within one year as applicable.
    • Organ‑specific testing per organ (e.g., MELD/INR for liver; GFR for kidney; echo/right heart cath for heart; PFTs and 6‑minute walk for lung).
    • Detailed psychosocial evaluation within 12 months for kidney and six months for other transplants; annual dental evaluation and clearance.

    Transplant Center Requirements

    Note

    Center and program requirements referenced; specific accreditation/volume criteria not listed here

    Policy references transplant service providers and transplant programs and notes applicable accreditation and regulatory standards (FACT, OPTN/UNOS, CMS) but does not list specific center accreditation or volume requirements in this excerpt.

    Post-Transplant Follow-Up Coverage

    Post-transplant follow-up office visits — authorization & documentation
    Prior authorization requiredPost‑transplant follow‑up office visits require an appropriate prior authorization form and the inpatient transplant discharge summary or history & physical from the transplant admission.
    Separate authorization for admissionsInpatient transplant admissions require separate prior authorization and are not covered under evaluation/listing or post‑transplant follow‑up authorizations.
    Other unrelated servicesServices unrelated to post‑transplant follow‑up office visits may require separate authorization per the health plan's prior authorization tool—providers should verify via plan tools.
    Policy Summary
    PayerWellCare
    PolicyTransplant Service Documentation Requirements
    Policy CodePolicy CP.MP.247
    Change TypeAdded and revised documentation and authorization requirements
    Effective Date
    Next Review Date
    Key ActionSubmit a completed prior authorization form and the specified supporting documentation (history & physical, labs, organ-specific testing, psychosocial evaluation, and discharge summary for post-transplant visits) to obtain authorization.
    SourceLink
    On This Page
    Coverage CriteriaCoding & TimingProvider Actions & Authorization RequirementsDefinitionsOrgan- and Candidate-Specific Evaluation RequirementsContraindicationsEvaluation RequirementsTransplant Center RequirementsPost-Transplant Follow-Up Coverage
  1. Authorization requires submission of the specified clinical documentation listed in the policy (history/physical, labs, organ‑specific testing, psychosocial evaluation, etc.).
  2. Documentation must align with referenced guidelines (UNOS/OPTN, KDIGO, FACT, CMS) and applicable legal/regulatory requirements.
  3. Denial Risk

    Include prior authorization form and required documentation or risk denial

    Requests for transplant evaluation, listing, post‑transplant follow‑up, or continuity‑of‑care authorizations must include the specified prior authorization form and required clinical documentation; failure to include required forms or documentation may result in denial.

    • Include the Health Plan’s prior authorization form with every request.
    • Lack of required documentation or an appropriate prior authorization form may result in denial of the request.
    Denial Risk

    Coverage terms, exclusions, and legal conflicts may trigger denial

    Coverage decisions and benefit administration are subject to all terms, conditions, exclusions, and limitations of the member’s coverage documents; conflicts with state Medicaid/Medicare rules or plan documents may affect coverage and could trigger denial.

    • Verify member benefits and any state Medicaid/Medicare requirements; coverage may vary by contract and state law.
    • Discrepancies between this policy and coverage documents or legal requirements are resolved in favor of applicable law or plan documents.
    Documentation Required

    Required documentation: evaluation, listing, post‑transplant follow‑up, and continuity of care

    Submit the specified clinical documentation for evaluation, listing, post‑transplant follow‑up, and continuity of care authorizations, including history & physical, medication list, basic labs, organ‑specific testing, infectious disease screening, psychosocial evaluation, dental clearance, and prior insurer/UNOS documentation for continuity of care.

    • For transplant evaluation: appropriate prior authorization form and a routine complete history and physical within one year (HPI, med list, past medical/family/social history, ROS, physical exam with height, weight, BMI).
    • For initial/subsequent listing: prior authorization form; letter of medical necessity signed by transplant service provider; H&P performed by transplant service provider within 12 months for kidney or 6 months for other transplants; basic labs within those timeframes; organ‑specific testing/imaging as listed; annual dental evaluation/clearance; routine health screenings (not required for autologous stem cell transplant); comorbidity testing/clearance; drug screen within 90 days; infectious disease screening within one year as applicable; detailed psychosocial evaluation within 12 months for kidney and 6 months for other transplants.
    • For continuity of care: documentation of prior insurer coverage, prior authorization evidence from previous insurer, and a copy of the UNOS listing.
    Documentation Required

    Post‑transplant follow‑up: include prior authorization form and discharge summary/H&P

    For post‑transplant follow‑up office visit prior authorization requests, include the appropriate prior authorization form plus the inpatient transplant admission discharge summary or the inpatient history & physical from the transplant admission.

    • If requesting authorization for services unrelated to post‑transplant follow‑up office visits, verify separate authorization requirements via the health plan's prior authorization tool.
    Documentation Required

    Submit documentation that supports medical necessity per plan and law

    Providers must submit documentation demonstrating medical necessity consistent with the Health Plan’s coverage documents, applicable laws/regulations, and generally accepted standards of medical practice; documentation should reference relevant guidelines as needed.

    • Documentation must support that the requested transplant service meets the plan’s medical necessity criteria and align with referenced guidance (UNOS, OPTN, KDIGO, FACT, CMS).
    • Providers are responsible for complying with applicable legal and regulatory requirements when submitting documentation.
    Prior Authorization

    Requests must include all specified documentation and prior authorization form

    Prior authorization requests must include the specific documentation listed in this policy (H&P, labs, organ‑specific testing, infectious disease screening, psychosocial evaluation, dental clearance, drug screen, letter of medical necessity, prior authorization form); missing required items may result in denial.

    • Requests for evaluation, listing, post‑transplant follow‑up, or continuity of care must include the specified documentation and prior authorization form.
    • Approved evaluation requests are effective for six months; approved listing requests are effective for 12 months—transplant admissions need separate authorization.
    Note
    Autologous HCT
    TermAutologous hematopoietic cell transplantation (HCT): use of a patient’s own hematopoietic cells to rebuild bone marrow following intensive chemotherapy and/or radiation therapy.
    PurposeTreatment of certain malignancies (e.g., multiple myeloma, Hodgkin lymphoma, acute myeloid leukemia) and select nonmalignant conditions as indicated by treating center.
    Evaluation notesPretransplant evaluation should include assessment of comorbidities, disease status, clinical assessment, labs, infectious disease screening, cardiac and pulmonary assessments, bone marrow/CNS evaluation, and functional status (ECOG or Karnofsky).
    Allogeneic HCT
    TermAllogeneic hematopoietic cell transplantation (HCT): use of hematopoietic cells from another person (related/unrelated donor or cord blood) to treat hematologic cancers and marrow disorders.
    Key requirementsPretransplant assessment includes detailed H&P, chest x‑ray, ECG, pulmonary function tests, cardiac function study, laboratory tests including infectious exposure assessment, and donor identification and risk assessment.
    Risk assessmentUse of scoring systems (e.g., EBMT risk score, HCT‑CI, Karnofsky) may help estimate mortality risk and inform candidacy and counseling.
    NCD (National Coverage Determination)
    TermNational Coverage Determination (NCD): a Medicare/ CMS determination addressing coverage for specific transplant services and indications.
    RelevancePolicy references multiple CMS NCDs for transplant types (e.g., adult/pediatric liver, heart, pancreas, intestinal, stem cell transplantation) as applicable to coverage determinations.
    Provider actionProviders should verify applicable NCD/LCD requirements when submitting prior authorization and medical necessity documentation for transplant services.
    FACT (Foundation for the Accreditation of Cellular Therapy)
    TermFACT: Foundation for the Accreditation of Cellular Therapy—standards for hematopoietic cellular therapy product collection, processing, and administration and for transplant program quality.
    RoleReferenced as a standard source informing transplant center and cellular therapy requirements used in assessing documentation and practice standards.
    ExpectationCenters and providers should follow FACT standards where applicable and align documentation with referenced guidance when submitting authorization requests.
    Echocardiogram and right heart catheterization results including pulmonary vascular resistance (PVR); NYHA class and peak VO2 results.
    N/A

    Infectious disease screening also applies as listed.

    Lung: Pulmonary function tests, chest x-ray and/or CT imaging, and six-minute walk test.N/A

    Infectious disease screening also applies as listed.

    Pancreas: Body mass index (BMI) and history of insulin treatment.N/A

    C-peptide was removed from criteria per revisions.

    Intestine/Multivisceral: Documentation of failed total parenteral nutrition (TPN).N/A
    Stem cell (autologous and allogeneic): Most recent bone marrow biopsy as indicated; most recent ECOG or Karnofsky performance score; donor identification documentation for allogeneic transplants; chest x-ray, ECG, pulmonary function tests, cardiac function study, and laboratory tests including assessment of prior infectious exposures.N/A

    Autologous HCT has fewer routine health screening requirements; functional status assessment recommended (ECOG or Karnofsky).